Trial Profile
Efficacy and Safety Study of Levemir (Insulin Detemir) to Treat Type 1 and 2 Diabetes Mellitus.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Insulin detemir (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Novo Nordisk
- 17 Dec 2009 Actual end date changed from Apr 2009 to May 2009 as reported by ClinicalTrials.gov.
- 16 Oct 2009 Actual number of patients (1000) added as reported by ClinicalTrials.gov.
- 01 May 2009 Planned number of patients changed from 1000 to 980 as reported by ClinicalTrials.gov.